Podcasts about hiv center

Dr. Phi Kreniske is Assistant Professor at Columbia University and CUNY. Phill also works in the HIV Center for Clinical and Behavioral Studies at the New York State Psychiatric Institute and Columbia University. In this episode, we talk about Phil's recent paper: Brief Report: Antiretroviral Treatment Use Over Time Among Adolescents and Young Adults in the Rakai Community Cohort Study, 2011–2020 published in JAIDS.

This week on Life Science Success, we're excited to welcome Donald Zinn, a seasoned professional with nearly three decades of experience in the biotech, pharmaceutical, and medical device industries. Beyond his executive roles, Don contributes to the National Institutes of Health (NIH) as a Commercialization Grant Reviewer and has played a pivotal role at Crossject, leading their needle-free auto-injector platform to global success since the onset of COVID.   Donald Zinn's Background and Experience: Donald Zinn, the Vice President of US Business at Crossject, has nearly 30 years of experience in the life sciences industry. He started his career with an undergraduate degree from UMBC and went on to innovate in the field by inventing dry process microarray during his time at the Uniform Services University. His journey included roles such as lab manager at Georgetown University's HIV Center, and leadership positions in companies focused on oncology, infectious diseases, and more. Crossject's Needle-Free Auto Injector: Zinn is part of the Crossject team, working on a needle-free auto injector, which he finds to be an exciting and innovative technology. This device is designed to deliver medications quickly and without the need for needles, addressing needle phobia and improving patient compliance. Demonstration of the Injector's Ease of Use: During the podcast, a demonstration was discussed showing how the injector works, including its ability to administer medication through clothing. This feature is particularly advantageous in emergency situations where speed and ease of use are critical. Focus on Partnerships and Market Expansion: Zinn emphasizes the importance of finding the right partners worldwide to distribute Crossject's needle-free injector. The company aims to select partners based on their expertise and market presence to ensure the technology is accessible to a broad audience. Future Prospects and Industry Impact: The conversation highlighted the potential of Crossject's technology to revolutionize drug delivery, especially for emergency medications like epinephrine. The ease of use, coupled with the effectiveness of the needle-free injector, presents a significant advancement in patient care and medication administration.

In this episode, we introduce ourselves and discuss what brought us to pursue our respective careers in public health and data science, and what eventually led us to be part of the HIV Center.

Hosted by Columbia University School of Professional Studies Dean, Jason Wingard, Talks@Columbia and the Learn For Life podcast presents timely thought leadership on crucial issues facing academia and industry today. Robert Klitzman, M.D. Academic Director, M.S. in Bioethics Program, School of Professional Studies; Professor of Psychiatry (in Sociomedical Sciences), Columbia University Medical Center https://sps.columbia.edu/academics/masters/bioethics Robert Klitzman, M.D., is a professor of psychiatry at the College of Physicians and Surgeons and the Joseph Mailman School of Public Health, and the Academic Director of the Master of Science in Bioethics program at Columbia University. He co-founded and for five years co-directed the Columbia University Center for Bioethics, and directed the Ethics and Policy Core of the HIV Center for 10 years. He has published over 120 scientific journal articles, eight books, and numerous chapters on critical issues in bioethics including genetics, neuroethics, HIV prevention, research ethics, and doctor-patient relationships. Klitzman has received numerous awards for his work, including fellowships from the John Simon Guggenheim Foundation, the Russell Sage Foundation, the Commonwealth Fund, the Aaron Diamond Foundation, and the Rockefeller Foundation. He is a member of the Empire State Stem Cell Commission and served on the U.S. Department of Defense’s Research Ethics Advisory Panel. He is a Distinguished Fellow of the American Psychiatric Association, a member of the Council on Foreign Relations, and a regular contributor to the New York Times and CNN.

The Center for Nonprofit Strategy and Management at Baruch College and the HIV Center for Clinical and Behavioral Studies at Columbia University present a panel discussion on AIDS activism.

The Center for Nonprofit Strategy and Management at Baruch College and the HIV Center for Clinical and Behavioral Studies at Columbia University present a panel discussion on AIDS activism.

Dr. Robert Remien, a Professor of Clinical Psychology (in Psychiatry) at the HIV Center for Clinical and Behavioral Studies, discusses HIV adherence and prevention and his focus on behavioral research. Our interviewer is Leif Mitchell.

Ronnie welcomes Linda Loffredo, of the HIV Center for Clinical and Behavioral Studies at the New York State Psychiatric Institute and Columbia University.